logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 20 of 29 Items
Showing 1 - 20 of 29 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Sequelae following an epidemic of meningococcal meningitis in Niger in 2022

Idrissa AA, Atti S, Wasaulua RK, Kazadi S, Sani O,  et al.
2025-05-22 • PLOS One
2025-05-22 • PLOS One

BACKGROUND

The management of post-meningitis sequelae is a priority in the WHO Roadmap to Defeat Meningitis by 2030. Nonetheless, the prevalence of sequelae in ...

Journal Article
|
Research

Clinical utility of the FilmArray® meningitis/encephalitis panel in children with suspected central nervous system infection in a low-resource setting – a prospective study in southwestern Uganda

Rasti R, Kumbakumba E, Nanjebe D, Mlotshwa P, Nassejje M,  et al.
2025-03-22 • BMC Infectious Diseases
2025-03-22 • BMC Infectious Diseases

BACKGROUND

In low-resource settings, limited laboratory capacity adds to the burden of central nervous system (CNS) infections in children and spurs overuse of ...

Conference Material
|
Poster

Factors associated with death among meningitis patients during the 2022-2023 epidemic in Jigawa State, Nigeria

Yakum MN, Gignoux E
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024
Conference Material
|
Abstract

Sequelae following an epidemic of meningococcal meningitis in Niger

Idrissa AA, Atti S, Wasaulua RK, Kazadi S, Guindo O,  et al.
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023
INTRODUCTION
MSF supported Niger’s Ministry of Health (MoH) in responding to a serogroup C meningococcal meningitis epidemic in Magaria and Dungass Districts in 2022. WHO’s global ro...
Conference Material
|
Slide Presentation

Sequelae following an epidemic of meningococcal meningitis in Niger

Idrissa AA, Atti S, Wasaulua RK, Kazadi S, Guindo O,  et al.
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023
Journal Article
|
Case Report/Series

Spontaneous nosocomial Proteus mirabilis meningitis in a Human Immunodeficiency Virus (HIV)-infected adult patient: a case report

Sood R, Walo C, Burton R, Khalife M, Dicko A,  et al.
2023-02-09 • Journal of Medical Case Reports
2023-02-09 • Journal of Medical Case Reports
BACKGROUND
Gram-negative bacillary meningitis remains a rare occurrence, even in patients with human immunodeficiency virus. Current literature only describes anecdotal cases of spon...
Journal Article
|
Commentary

Access to medicines for treating people With cryptococcal meningitis

Burry J, Casas CP, Ford NP
2022-08-29 • Clinical Infectious Diseases
2022-08-29 • Clinical Infectious Diseases
Cryptococcal meningitis accounts for 1 in 5 AIDS-related deaths globally. World Health Organization guidelines strongly recommend a single high dose of liposomal amphotericin B as part o...
Journal Article
|
Research

Meningitis Dipstick Rapid Test: Evaluating Diagnostic Performance During an Urban Neisseria Meningitidis Serogroup A Outbreak, Burkina Faso, 2007

Rose AMC, Mueller JE, Gerstl S, Njanpop-Lafourcade BM, Page AL,  et al.
2010-06-11 • PLOS One
2010-06-11 • PLOS One
Meningococcal meningitis outbreaks occur every year during the dry season in the "meningitis belt" of sub-Saharan Africa. Identification of the causative strain is crucial before launchi...
Journal Article
|
Review

Global practices of meningococcal vaccine use and impact on invasive disease

Ali A, Jafri RZ, Messonnier N, Tevi-Benissan C, Durrheim DN,  et al.
2014-01-01 • Pathogens and Global Health
2014-01-01 • Pathogens and Global Health
A number of countries now include meningococcal vaccines in their routine immunization programs. This review focuses on different approaches to including meningococcal vaccines in countr...
Journal Article
|
Research

Spatial dynamics of meningococcal meningitis in Niger: observed patterns in comparison with measles

Bharti N, Broutin H, Grais RF, Ferrari MJ, Djibo A,  et al.
2011-10-05 • Epidemiology and Infection
2011-10-05 • Epidemiology and Infection
Throughout the African meningitis belt, meningococcal meningitis outbreaks occur only during the dry season. Measles in Niger exhibits similar seasonality, where increased population den...
Journal Article
|
Research

Field evaluation of two rapid diagnostic tests for Neisseria meningitidis serogroup A during the 2006 outbreak in Niger

Rose AMC, Gerstl S, Mahamane AE, Sidikou F, Djibo S,  et al.
2009-10-05 • PLOS One
2009-10-05 • PLOS One
The Pastorex((R)) (BioRad) rapid agglutination test is one of the main rapid diagnostic tests (RDTs) for meningococcal disease currently in use in the "meningitis belt". Earlier evaluati...
Journal Article
|
Research

Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007-08 and 2014-15: a qualitative and quantitative assessment

Parikh S, Newbold L, Slater S, Moschioni M, Lucidarme J,  et al.
2017-07-01 • Lancet Infectious Diseases
2017-07-01 • Lancet Infectious Diseases
BACKGROUND
The UK introduced 4CMenB-a multicomponent vaccine against serogroup B meningococcal disease-into the national infant immunisation programme in September, 2015. The Meningo...
Journal Article
|
Commentary

Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries

Loyse A, Burry J, Cohn J, Ford NP, Chiller T,  et al.
2018-10-18 • Lancet Infectious Diseases
2018-10-18 • Lancet Infectious Diseases
In 2018, WHO issued guidelines for the diagnosis, prevention, and management of HIV-related cryptococcal disease. Two strategies are recommended to reduce the high mortality associated w...
Journal Article
|
Commentary

Cryptococcal meningitis: A neglected NTD?

Molloy SF, Chiller T, Greene GS, Burry J, Govender NP,  et al.
2017-06-29 • PLOS Neglected Tropical Diseases
2017-06-29 • PLOS Neglected Tropical Diseases
Journal Article
|
Research

Measles vaccination coverage survey in Moba, Katanga, Democratic Republic of Congo, 2013: need to adapt routine and mass vaccination campaigns to reach the unreached

Funk A, Uadiale K, Kamau C, Caugant DA, Ango U,  et al.
2014-12-29 • PLoS Currents
2014-12-29 • PLoS Currents
The Democratic Republic of Congo (DRC) has committed to eliminate measles by 2020. In 2013, in response to a large outbreak, Médecins Sans Frontières conducted a mass vaccination campaig...
Journal Article
|
Short Report

Continuing effectiveness of serogroup a meningococcal conjugate vaccine, Chad, 2013

Gamougam K, Daugla DM, Toralta J, Ngadoua C, Fermon F,  et al.
2015-01-01 • Emerging Infectious Diseases
2015-01-01 • Emerging Infectious Diseases
In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated...
Journal Article
|
Commentary

Responding to the evidence for improved treatment for Cryptococcal Meningitis in resource-limited settings

Milani B, Ford NP
2012-03-14 • South African Medical Journal
2012-03-14 • South African Medical Journal
Journal Article
|
Review

Pneumococcal meningitis outbreaks in Africa, 2000-2018: systematic literature review and meningitis surveillance database analyses

Franklin K, Kwambana-Adams B, Lessa FC, Soeters HM, Cooper L,  et al.
2021-09-01 • Journal of Infectious Diseases
2021-09-01 • Journal of Infectious Diseases
BACKGROUND
The meningitis belt of sub-Saharan Africa has traditionally experienced large outbreaks of meningitis mainly caused by Neisseria meningitidis. More recently, Streptococcus...
Journal Article
|
Research

Long-acting chloramphenicol versus intravenous ampicillin for treatment of bacterial meningitis

Pécoul B, Varaine FFV, Keita M, Soga G, Djibo A,  et al.
1991-10-05 • Lancet
1991-10-05 • Lancet
In most developing countries, bacterial meningitis (BM) is associated with a high case-fatality rate. The search for a simple, convenient, and inexpensive antibiotic treatment remains a ...
Journal Article
|
Research

Seasonal upsurge of pneumococcal meningitis in the Central African Republic

Crellen T, Rao VB, Piening T, Zeydner J, Siddqui MR
2018-10-19 • Wellcome Open Research
2018-10-19 • Wellcome Open Research
A high incidence of bacterial meningitis was observed in the Central African Republic (CAR) from December 2015 to May 2017 in three hospitals in the northwest of the country that are wit...